Strangvac
Active substance
ATC code
Species
Horses and ponies
Indications
Active immunisation of horses and ponies from 5 months of age for:
- Reduction of body temperature increase, coughing, inappetence, difficulty swallowing, and changes in demeanour in the acute stage of infection with Streptococcus equi.
- Reduction of number of abscesses within submandibular and retropharyngeal lymph nodes.
Onset of immunity: 2 weeks after the second vaccination dose.
Duration of immunity: 2 months after the second vaccination dose.
Dose to be administered and administration route
Intramuscular use.
Shake the vial well before use. Avoid multiple vial broaching. Avoid introduction of contamination.
It is recommended that all horses and ponies in a stable are vaccinated.
Vaccination schedule:
Primary vaccination course:
Administer one dose (2 ml) by intramuscular injection, followed by a second dose (2 ml) four weeks later.
Revaccination:
In horses at high risk of S. equi infections it is recommended to repeat the primary vaccination regimen after two months.
Adverse reactions
A transient increase in body temperature of up to 2.6 °C may occur very commonly and last for one to five days following vaccination. Transient local tissue reactions are very commonly seen at the injection site, characterised by heat, pain and swelling (up to 5 cm diameter), and last for up to five days. Prevalence of injection site reactions are more pronounced after the second primary dose or re-vaccinations including increased swelling of up to 8 cm diameter. Ocular discharge is very commonly seen, which may be mucopurulent and present from both eyes for one to five days after vaccination. Loss of appetite and demeanour changes are common for up to one day. Anaphylactic-like reactions occur in very rare cases. Potential complications from vaccination and S. equi infection following challenge were not investigated.
The frequency of adverse reactions is defined using the following convention:
- very common (more than 1 in 10 animals treated displaying adverse reaction(s))
- common (more than 1 but less than 10 animals in 100 animals treated)
- uncommon (more than 1 but less than 10 animals in 1,000 animals treated)
- rare (more than 1 but less than 10 animals in 10,000 animals treated)
- very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
| PRICE | Only for registered vets. Create a free profile to access all features.. Login |
|---|---|
| Art. Nr. | 52661/5000 |
| EAN | 5701170438086 |
